The Food and Drug Administration gave its blessing to a new GLP-1 pill last week, and Houston will play a role in its manufacturing. Orforglipron, under the brand name Foundayo, received FDA approval ...
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
Novartis, Amgen and Eli Lilly are among the pharmaceutical companies developing drugs to lower levels of a particularly bad form of cholesterol called Lp(a) and potentially prevent heart attacks. Lp(a ...